(Alliance News) - EssilorLuxottica SA on Wednesday reported a rise in first quarter revenue, marking the third consecutive quarter of growth.

The Paris-based eyewear maker reported revenue of EUR7.18 billion for three months to March 3, up 4.1% from EUR6.85 billion a year ago, or up 11% at constant exchange rates.

Of total revenue, Professional Solutions totalled EUR3.36 billion, up 11% at constant exchange rates and 3.9% on a reported basis. Direct to Consumer revenue was EUR3.76 billion, up 11% at constant exchange rates and 4.2% on a reported basis.

Regionally, North America revenue climbed 13% at constant rates, while Europe, Middle East and Africa rose 9.5%. Asia Pacific revenue grew by 9.8%. Latin America rose 6.7%.

Chair and Chief Executive Officer Francesco Milleri and Deputy CEO Paul du Saillant said in a joint statement: "With the third consecutive quarter of double-digit growth, we once again demonstrate the strength and relevance of our strategy and our ability to deliver against it. We continued to drive robust momentum across all regions and businesses, driven by the enduring solidity of our vision care and eyewear activities and a steady pipeline of innovation.

The executives also noted the "continued robust traction of our myopia management platform and in the strong results delivered by wearables, fueled by the successful launch of Ray-Ban Meta's new optical-first styles."

"At the same time, we continued to expand our retail footprint with our investment in Top Charoen and its 2,000-store network in Thailand, extending our world-class vision care and eye health ecosystem closer to millions more people," they continued.

On average over the next five years, EssilorLuxottica expects "solid" revenue growth and "broadly aligned" adjusted operating profit growth, at constant exchange rates.

"Rooted in our medtech transformation, the long-term outlook reflects the scaling of our AI-driven healthcare platform and the next phase of our journey toward becoming a global leader in advanced and integrated eye health, with the ambition to enhance human performance," the company said.

EssilorLuxottica shares closed down 2.5% at EUR201.50 each in Paris on Wednesday.

By Aidan Lane, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Ämnen i artikeln

EssilorLuxottica SA

Senast

201,50

1 dag %

−2,52%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån